Notably, CD46 and TREM1 may collaboratively shape a tumor-promoting microenvironment: CD46 potentially mediates immunosuppression via T-cell regulation, while TREM1 drives sustained production of pro-inflammatory factors (e.g., TNF-α, IL-6) by amplifying NF-κB signaling. The gene discussed is NFKB1; the disease is neoplasm.